HLB Life Science Co. Ltd (067630) — Cash Flow Reinvestment Rate
HLB Life Science Co. Ltd (067630) has a Cash Flow Reinvestment Rate of 2.19x as of March 2023, reinvesting ₩7.79 Billion (capex ₩3.52 Billion plus investments ₩-4.27 Billion) from operating cash flow of ₩3.55 Billion. Explore capital reinvestment ratio of HLB Life Science Co. Ltd to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
HLB Life Science Co. Ltd Cash Flow Reinvestment Rate (2012–2020)
Historical reinvestment intensity for HLB Life Science Co. Ltd across 4 annual periods. Also explore HLB Life Science Co. Ltd (067630) total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for HLB Life Science Co. Ltd (2012–2020)
Year-by-year capital reinvestment analysis for HLB Life Science Co. Ltd. For live market cap and broader valuation context, see 067630 stock market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2020 | 12.05x | ₩24.21 Billion | ₩2.01 Billion | ₩8.41 Billion | ▲ +9080.6% |
| 2014 | 0.13x | ₩1.37 Billion | ₩10.43 Billion | ₩236.21 Million | ▲ +651.5% |
| 2013 | 0.02x | ₩51.48 Million | ₩2.95 Billion | ₩51.48 Million | ▼ -97.3% |
| 2012 | 0.66x | ₩9.18 Billion | ₩13.97 Billion | ₩9.18 Billion | — |